PHARMACY

Watson, J&J settle lawsuit over generic contraceptive

BY Alaric DeArment

PARSIPPANY, N.J. — Subsidiaries of Watson Pharmaceuticals and Johnson & Johnson have settled a lawsuit filed by the latter when Watson attempted to market a generic version of one of its contraceptive drugs.

Watson said Wednesday that Watson Labs and Janssen Pharmaceuticals had settled a patent litigation suit filed in October 2008 over the drug Ortho Tri-Cyclen Lo (norgestimate and ethinyl estradiol). Janssen filed the suit after Watson sought Food and Drug Administration approval for the drug prior to the expiration of a patent covering it; the patent covering the drug’s use in adults is scheduled to expire in June 2019, according to FDA records.

Under the settlement, Janssen will manufacture and supply Watson with an authorized generic version of the drug, while Watson will have the right to market and distribute it and the end of 2015. Other terms of the deal were not disclosed.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

FDA approves Sanofi lice treatment

BY Alaric DeArment

BRIDGEWATER, N.J. — The Food and Drug Administration has approved a head lice treatment made by Sanofi, the drug maker said.

Sanofi announced the approval of Sklice (ivermectin) lotion in the 0.5% strength for patients ages 6 months and older. According to Sanofi, head lice infest an estimated 6 to 12 million children ages 3 to 11 years and costs as much as $1 billion in lost school days and lost work for parents.

"The approval of Sklice lotion provides physicians and parents with a new treatment option for head lice, a condition that is notoriously frustrating to treat," Sanofi-Topaz general manager Kenneth Guito said. "Through a unique mode of action, Sklice lotion resolves most head lice infestations in one application and is very well-tolerated."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Winn-Dixie to offer free cholesterol screenings, guides this month

BY Allison Cerra

JACKSONVILLE, Fla. — Winn-Dixie is putting an emphasis on heart health by highlighting its pharmacy offerings.

The company said guests can receive free cholesterol screenings at Winn-Dixie pharmacies and is partnering with the Agency for Healthcare Research and Quality to offer a free treating high cholesterol guide, which is available in English and Spanish, in honor of American Heart Month.

“As part of the healthcare team, your Winn-Dixie pharmacist plays a significant role in the management and prevention of cardiovascular disease,” Winn-Dixie VP pharmacy John Fegan said. “With pharmacies in a majority of our stores, Winn-Dixie is distinctively positioned to offer guests expert consultation, disease prevention information and medications alongside an abundant selection of heart healthy meal and dietary solutions.”

To learn more about additional pharmacy services offered at Winn-Dixie can be found here.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES